Terms: = Skin cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
58 results:
1. Superficial acral calcified chondroid mesenchymal neoplasm harboring an FN1::fgfr2 fusion and review of the literature.
Machado I; Damaskou V; Ioannidis E; Jour G; Linos K
J Cutan Pathol; 2024 May; 51(5):338-344. PubMed ID: 38328983
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis and Evaluation of Novel
Yao J; Fan M; Peng J; Luo H; Lu J
Mol Pharm; 2024 Feb; 21(2):895-903. PubMed ID: 38170629
[TBL] [Abstract] [Full Text] [Related]
3. A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma.
Uson PLS; Bearss J; Babiker HM; Borad M
Expert Opin Drug Saf; 2023; 22(8):637-641. PubMed ID: 37363820
[TBL] [Abstract] [Full Text] [Related]
4. Age-related next-generation sequencing mutational analysis in 1196 melanomas.
Santamaria-Barria JA; Matsuba C; Khader A; Scholar AJ; Garland-Kledzik M; Fischer TD; Essner R; Salomon MP; Mammen JMV; Goldfarb M
J Surg Oncol; 2023 Jun; 127(7):1187-1195. PubMed ID: 36938777
[TBL] [Abstract] [Full Text] [Related]
5. FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with fgfr2 Fusion or Other Rearrangement.
Patel TH; Marcus L; Horiba MN; Donoghue M; Chatterjee S; Mishra-Kalyani PS; Schuck RN; Li Y; Zhang X; Fourie Zirkelbach J; Charlab R; Liu J; Yang Y; Lemery SJ; Pazdur R; Theoret MR; Fashoyin-Aje LA
Clin Cancer Res; 2023 Mar; 29(5):838-842. PubMed ID: 36206041
[TBL] [Abstract] [Full Text] [Related]
6. Bilateral parotid glands aplasia: a case report and literature review.
Kuralt H; Fidler A; Blatnik A; Novaković S; Plavc G
Oral Radiol; 2022 Jul; 38(3):423-429. PubMed ID: 35076829
[TBL] [Abstract] [Full Text] [Related]
7. The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis.
Ranjan R; Partl R; Erhart R; Kurup N; Schnidar H
Comput Biol Med; 2021 Dec; 139():104952. PubMed ID: 34739967
[TBL] [Abstract] [Full Text] [Related]
8. Intragenic NF1 deletions in sinonasal mucosal malignant melanoma.
Riobello C; Casanueva Muruais R; Suárez-Fernández L; García-Marín R; Cabal VN; Blanco-Lorenzo V; Franchi A; Laco J; López F; Llorente JL; Hermsen MA
Pigment Cell Melanoma Res; 2022 Jan; 35(1):88-96. PubMed ID: 34547192
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of fast-growing melanomas.
Gaudy-Marqueste C; Macagno N; Loundou A; Pellegrino E; Ouafik L; Budden T; Mundra P; Gremel G; Akhras V; Lin L; Cook M; Kumar R; Grob JJ; Nagore E; Marais R; Virós A
J Am Acad Dermatol; 2022 Feb; 86(2):312-321. PubMed ID: 34280484
[TBL] [Abstract] [Full Text] [Related]
10. Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic fgfr2 mutations.
Theiler M; Weibel L; Christen-Zaech S; Carmignac V; Sorlin A; Neuhaus K; Chevarin M; Thauvin-Robinet C; Philippe C; Faivre L; Vabres P; Kuentz P
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2085-2090. PubMed ID: 33930231
[TBL] [Abstract] [Full Text] [Related]
11. Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.
Tsimberidou AM; Vo HH; Subbiah V; Janku F; Piha-Paul S; Yilmaz B; Gong J; Naqvi MF; Tu SM; Campbell M; Meric-Bernstam F; Naing A
Oncologist; 2021 Jul; 26(7):558-e1098. PubMed ID: 33491277
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic Alterations in Keratinocyte Carcinoma.
Yao Q; Epstein CB; Banskota S; Issner R; Kim Y; Bernstein BE; Pinello L; Asgari MM
J Invest Dermatol; 2021 May; 141(5):1207-1218. PubMed ID: 33212152
[TBL] [Abstract] [Full Text] [Related]
13. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and fgfr2 Mutations in Mice.
Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
[TBL] [Abstract] [Full Text] [Related]
14. Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
Sun X; Zuo K; Yao Q; Zhou S; Shui R; Xu X; Bi R; Yu B; Cheng Y; Tu X; Lu H; Yang W
Mod Pathol; 2020 Dec; 33(12):2473-2482. PubMed ID: 32504034
[TBL] [Abstract] [Full Text] [Related]
15. Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.
Gadea A; Hernández-Muñoz I; Vicente A; Andrades E; García-Calvente M; Camacho L; Fernandez-Rodríguez C; Bellosillo B; Pujol R; Toll A
J Med Genet; 2020 Sep; 57(9):601-604. PubMed ID: 31937562
[No Abstract] [Full Text] [Related]
16. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR
Lehmann BD; Abramson VG; Sanders ME; Mayer EL; Haddad TC; Nanda R; Van Poznak C; Storniolo AM; Nangia JR; Gonzalez-Ericsson PI; Sanchez V; Johnson KN; Abramson RG; Chen SC; Shyr Y; Arteaga CL; Wolff AC; Pietenpol JA;
Clin Cancer Res; 2020 May; 26(9):2111-2123. PubMed ID: 31822498
[TBL] [Abstract] [Full Text] [Related]
17. Potentially actionable fgfr2 high-level amplification in thymic sebaceous carcinoma.
Porubsky S; Jessup P; Kee D; Sharma R; Ochi A; Xu H; Froelich JJ; Nott L; Scott C; Awad R; Moldovan C; Hardikar AA; Bohnenberger H; Küffer S; Ströbel P; Marx A
Virchows Arch; 2020 Feb; 476(2):323-327. PubMed ID: 31401665
[TBL] [Abstract] [Full Text] [Related]
18. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract] [Full Text] [Related]
19. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract] [Full Text] [Related]
20. Oncogenic mutations in histologically normal endometrium: the new normal?
Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
[TBL] [Abstract] [Full Text] [Related]
[Next]
